ICUSeaStar Medical Holding Corp

Nasdaq N/A


$ 4.11 $ -0.42 (-9.27 %)    

Monday, 10-Jun-2024 15:29:22 EDT
QQQ $ 464.41 $ 1.62 (0.35 %)
DIA $ 388.87 $ 0.52 (0.13 %)
SPY $ 535.22 $ 1.97 (0.37 %)
TLT $ 90.89 $ -0.14 (-0.15 %)
GLD $ 213.77 $ 0.68 (0.32 %)
$ 0.2194
$ 4.53
$ 4.13 x 100
$ 0.00 x 0
$ 3.90 - $ 4.75
$ 0.16 - $ 1.72
7,405,704
na
588,923
$ 0.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-16-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-16-2022 06-30-2022 10-Q
9 05-19-2022 03-31-2022 10-Q
10 04-06-2022 12-31-2021 10-K
11 11-17-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-24-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 seastar-medical--announces-the-publication-of-a-peer-reviewed-article-in-nature-scientific-reports-describes-the-mechanism-of-action-of-the-cos-selective-cytopheretic-device-in-the-immunomodulation-of-excessive-inflammation

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage medical device company developing proprietary solutions to...

 seastar-medical-holdings-publishes-manuscript-on-multiorgan-failure-patients-treated-with-selective-cytopheretic-device

SCD's ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical condi...

 seastar-medical-holding-q1-2024-adj-eps-019-misses-015-estimate

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate...

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 seastar-medical-holding-q4-eps-019-misses-013-estimate

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate...

 seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-and-commercial-launch-of-quelimmune-fda-approved-in-pediatric-patients

Company plans to hold a business update conference call in AprilDENVER, March 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Hold...